Results 211 to 220 of about 42,495 (262)
Some of the next articles are maybe not open access.

Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio

Clinical Research in Cardiology, 2010
Plasma BNP and NT-proBNP are often regarded as interchangeable parameters in assessing heart failure (HF) severity and prognosis. Renal failure results in disproportionate increases of NT-proBNP and an increased NT-proBNP/BNP ratio. Low kidney function is therefore considered particularly when NT-proBNP is used to assess HF.
Michael L X Fu   +2 more
exaly   +3 more sources

A chemiluminescence immunoassay for the detection of NT-proBNP

Analytical Biochemistry, 2020
The aim of the study was to assess the analytical performance of the HISCL NT-proBNP assay, a newly developed chemiluminescence immunoassay, for the detection of NT-proBNP.The within-run and total imprecision of the NT-proBNP assay were determined with HISCL cardiac marker controls.
Hui-Ling Lin   +2 more
exaly   +3 more sources

NT-proBNP Concentrations in Mountain Marathoners

Journal of Strength and Conditioning Research, 2010
The 76 amino acid N-terminal proB-type natriuretic peptide (NT-proBNP) is proposed for evaluating and monitoring heart pathologies characterized by myocardial wall stress. Strenuous exercise might generate transitory ischemia, myocardial stress, and diastolic left ventricular dysfunction, possibly inducing an increase of some biochemical parameter ...
G. Banfi   +6 more
openaire   +2 more sources

Performance of urinary NT-proBNP in ambulatory settings

Clinica Chimica Acta, 2022
NT-proBNP (N-terminal prohormone of brain natriuretic peptide) has been established as a useful biomarker in plasma for children with congenital heart disease (CHD). Plasma values were shown to correlate well with urinary values. We designed a study to investigate the general utility of urinary NT-proBNP in children with and without CHD in an ...
Nicole, Müller   +4 more
openaire   +2 more sources

NT-proBNP in the Mitral Valve Surgery

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2014
Prognosis and severity of mitral valve disease in patients are reflected in their natriuretic peptide levels. Patients in the upper margin of this range with severe mitral valve dysfunction also present with a range of myocardial dysfunction and symptomatic progression.
Konstantinos, Perreas   +9 more
openaire   +2 more sources

NT-ProBNP: The Mechanism Behind the Marker

Journal of Cardiac Failure, 2005
Brain natriuretic peptide (BNP) was isolated originally from porcine brain extracts but was soon defined as a cardiac natriuretic hormone. Together with the highly homologous atrial natriuretic peptide, it forms a dual natriuretic peptide system of the heart. The main stimulus for proBNP synthesis and secretion from cardiac myocytes is myocyte stretch.
openaire   +2 more sources

Effect of anemia on plasma concentrations of NT-proBNP

Clinica Chimica Acta, 2005
Concentrations of the amino-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) are increased in the blood of patients with heart failure. Understanding the variables that influence the concentrations of NT-proBNP is required to refine its clinical use criteria.
Monte S, Willis   +2 more
openaire   +2 more sources

BNP/NT‐ProBNP and Cardiac Pacing: A Review

Pacing and Clinical Electrophysiology, 2009
Natriuretic peptide (NP) levels (B‐type natriuretic peptide [BNP] and N‐terminal proBNP) are now widely used in clinical practice and cardiovascular research all over the world and have been incorporated into many cardiovascular guidelines for heart failure (HF).
Ru-Xing, Wang, Tao, Guo, Xiao-Rong, Li
openaire   +2 more sources

Home - About - Disclaimer - Privacy